A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis
article
OA: closed
CC0
⤵ 14 in-corpus citations
AI-generated summary
This study compared the effects of buserelin and danazol on plasma lipoproteins in patients undergoing treatment for pelvic endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Twelve patients receiving Buserelin and seven patients receiving danazol for treatment of endometriosis were studied to assess the effect of medication on plasma lipoproteins. Danazol significantly lowered plasma HDL-C levels at 6 months of treatment. Total plasma cholesterol was elevated at 6 months of therapy in the Buserelin group. No effect by either drug on plasma triglycerides was seen.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (6)
- Cholesterol, High Density Lipoprotein and Danazol via openalex
- Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis via openalex
- Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women via openalex
- W323827874 via openalex
- W2016752924 via openalex
- W2094768566 via openalex
Cited by (14)
- Danazol 2022
- Tratamiento endocrinológico de la endometriosis 1997
- Endometriosis: Current Management 1995
- GnRH Agonists in the Treatment of Endometriosis 1993
- Endocrine Treatment of Endometriosis 1992
- Endometriosetherapie mit Enantone®-Gyn Monats-Depot 1992
- Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol 1991
- Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin 1991
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study 1990
- Buserelin 1990
- Therapie der Endometriose 1989
- Erste klinische Erfahrungen bei der Behandlung der Endometriose mittels dem LH-RH-Analogon Zoladex Depot 1989
- Therapie der Endometriose 1989
- Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol 1989
Source provenance
- europepmc
- last seen: 2026-07-27T06:15:28.040536+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:20.810540+00:00
License: CC0
· commercial use OK